Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1064)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, TXG, BTSG, HNGE

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	8.07	709.97M	81.18M	-80.94M	-55.15M	-1.1809
VEEV Veeva Systems Inc	273.33	45.44B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	76.63	15.43B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	93.50	11.17B	638.78M	-22.66M	122.18M	-0.1744
BTSG Brightspring Health Services Inc	60.25	11.20B	13.65B	169.86M	412.12M	1.0758
HNGE Hinge Health Inc	97.67	7.71B	646.34M	-512.40M	202.76M	-6.6871

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa-Aktie (SOPH) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Muken Ross	Chief Executive Officer	Sep 21 '26	Sale	8.33	422	3,515	670,229

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, TEM, TXG, BTSG, HNGE

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Form 144 SOPHIA GENETICS SA For: 27 September By Investing.com - Investing.com South Africa

SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress

Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan

Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan

SOPHiA GENETICS (SOPH) Insider Trading Activity 2026 - MarketBeat

SOPHiA GENETICS SA(NasdaqGS: SOPH) added to S&P Global BMI Index - marketscreener.com

SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance

SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media

SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media

Chief Medical Officer Philippe Menu Sells 5,000 Shares of Sophia Genetics SA (SOPH) - GuruFocus

SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect - Seeking Alpha

SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - MarketBeat

SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 8,500 Shares of Stock - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 6,168 Shares of Stock - MarketBeat

Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media

SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat

Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat

Sophia Genetics SA (SOPH) Key Financial Ratios – Valuation, Profitability & More - Value Research

SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance

SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media

Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research

SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com

SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Sophia Genetics SA (SOPH) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat

SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media

SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CTO Sells $44,000.00 in Stock - MarketBeat

SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan

SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media

SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media

SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan

SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan

SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat

EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

SOPHiA Genetics Earnings Call Highlights Growth Push - TipRanks

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com

Sophia Genetics SA (SOPH) Chief Scientific Officer Zhenyu Xu Sel - GuruFocus

SOPHiA GENETICS (SOPH) Slips 1.57% as Shares Consolidate Between Key Support and ResistanceStock Surge Alerts - vinanet.vn

SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Sophia Genetics Sa-Aktie (SOPH) Insiderhandel

Ähnlich wie SOPH